GPD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.739200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.967590E-01
Normal-vs-Stage2
2.605000E-01
Normal-vs-Stage3
8.800200E-01
Normal-vs-Stage4
1.437360E-01
Stage1-vs-Stage2
9.542800E-01
Stage1-vs-Stage3
1.432750E-01
Stage1-vs-Stage4
3.868800E-01
Stage2-vs-Stage3
1.544760E-01
Stage2-vs-Stage4
2.635400E-01
Stage3-vs-Stage4
9.647500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.787400E-01
Normal-vs-AfricanAmerican
2.350000E-01
Normal-vs-Asian
3.905800E-01
Caucasian-vs-AfricanAmerican
8.033000E-01
Caucasian-vs-Asian
6.418400E-01
AfricanAmerican-vs-Asian
8.546200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.389400E-01
Normal-vs-Female
3.318200E-01
Male-vs-Female
2.122600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.966800E-01
Normal-vs-Age(41-60Yrs)
1.798620E-01
Normal-vs-Age(61-80Yrs)
3.420400E-01
Normal-vs-Age(81-100Yrs)
2.854800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.965800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.655200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.258200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.219700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.475800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.981600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.297600E-01
Normal-vs-Daily Drinker
3.441400E-01
Normal-vs-Weekly Drinker
5.971000E-01
Normal-vs-Occasional Drinker
8.775600E-02
Normal-vs-Social Drinker
3.357400E-01
Non Drinker-vs-Daily Drinker
2.979600E-01
Non Drinker-vs-Weekly Drinker
7.873800E-01
Non Drinker-vs-Occasional Drinker
1.202490E-02
Non Drinker-vs-Social Drinker
9.974000E-01
Daily Drinker-vs-Weekly Drinker
3.330400E-01
Daily Drinker-vs-Occasional Drinker
2.572400E-01
Daily Drinker-vs-Social Drinker
3.352600E-01
Weekly Drinker-vs-Occasional Drinker
3.488400E-02
Weekly Drinker-vs-Social Drinker
8.035800E-01
Occasional Drinker-vs-Social Drinker
2.688400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.548400E-02
Normal-vs-Grade 2
4.484000E-02
Normal-vs-Grade 3
9.540500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.629550E-01
Grade 1-vs-Grade 3
1.009590E-02
Grade 1-vs-Grade 4
8.548400E-02
Grade 2-vs-Grade 3
1.361800E-01
Grade 2-vs-Grade 4
4.484000E-02
Grade 3-vs-Grade 4
9.540500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.520600E-01
Normal-vs-NonDiabetic
2.819400E-01
Diabetic-vs-NonDiabetic
2.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.171400E-01
Normal-vs-NoPancreatitis
3.079200E-01
Pancreatitis-vs-NoPancreatitis
6.422300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.652000E-01
Normal-vs-N1
2.629200E-01
N0-vs-N1
5.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.243900E-02
Normal-vs-TP53-NonMutant
4.571400E-01
TP53-Mutant-vs-TP53-NonMutant
3.223300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
